Guan Wang, Yanan Zhao, Xiaoshan Zhang, Yu Zhang, Xinyi Zhang. Epiberberine attenuates diabetic atherosclerosis by inhibiting the Raf/MEK1/2/ERK1/2 pathway. // International Immunopharmacology. – DOI: 10.1016/j.intimp.2026.117664. – URL: https://www.sciencedirect.com/science/article/pii/S1567576926015122?dgcid=rss_sd_all
Guan Wang, Yanan Zhao, Xiaoshan Zhang, Yu Zhang, & Xinyi Zhang Epiberberine attenuates diabetic atherosclerosis by inhibiting the Raf/MEK1/2/ERK1/2 pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117664
Guan Wang, et al. “Epiberberine attenuates diabetic atherosclerosis by inhibiting the Raf/MEK1/2/ERK1/2 pathway.” International Immunopharmacology. doi:10.1016/j.intimp.2026.117664.
@article{Wang,
title = {Epiberberine attenuates diabetic atherosclerosis by inhibiting the Raf/MEK1/2/ERK1/2 pathway},
author = {Wang, Guan and Zhao, Yanan and Zhang, Xiaoshan and Zhang, Yu and Zhang, Xinyi},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2026.117664},
url = {https://www.sciencedirect.com/science/article/pii/S1567576926015122?dgcid=rss_sd_all}
}